SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-053949
Filing Date
2024-05-07
Accepted
2024-05-07 07:31:13
Documents
15
Period of Report
2024-05-06
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K agen-20240506.htm   iXBRL 8-K 49729
2 EX-4.1 agen-ex4_1.htm EX-4.1 147076
3 EX-99.1 agen-ex99_1.htm EX-99.1 37760
4 GRAPHIC img250783414_0.jpg GRAPHIC 35838
5 GRAPHIC img250783414_1.jpg GRAPHIC 9118
  Complete submission text file 0000950170-24-053949.txt   440121

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT agen-20240506.xsd EX-101.SCH 23892
18 EXTRACTED XBRL INSTANCE DOCUMENT agen-20240506_htm.xml XML 4505
Mailing Address 3 FORBES ROAD LEXINGTON MA 02421
Business Address 3 FORBES ROAD LEXINGTON MA 02421 781-674-4410
AGENUS INC (Filer) CIK: 0001098972 (see all company filings)

IRS No.: 061562417 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-29089 | Film No.: 24919619
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)